Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cario

Showing results (451-460 of 548) with videos related to

Pageof 55
Sort By:
Cell Reports. Medicine|April 29, 2023
Innate immune pathway modulator screen identifies STING pathway activation as a strategy to inhibit multiple families of arbo and respiratory virusesGustavo Garcia, Joseph Ignatius Irudayam, Arjit Vijey Jeyachandran, et al.
Cell Reports|October 14, 2025
Integrated genomic and transcriptomic profiling of glioblastoma reveals ecDNA-driven heterogeneity and microenvironmental reprogrammingWenshu Tang, Wing Lun Lee, Cario W S Lo, et al.
The Lancet. Haematology|December 4, 2018
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trialAndrea Biondi, Virginie Gandemer, Paola De Lorenzo, et al.
Haematologica|April 6, 2023
Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemiaJanina Heilmann, Simon Vieth, Anja Möricke, et al.
Nature Communications|June 7, 2016
Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemiaHenrik Lilljebjörn, Rasmus Henningsson, Axel Hyrenius-Wittsten, et al.
Blood Advances|July 15, 2024
A brain organoid/ALL coculture model reveals the AP-1 pathway as critically associated with CNS involvement of BCP-ALLPhilip Gebing, Stefanos Loizou, Sebastian Hänsch, et al.
Blood Cancer Journal|February 4, 2017
Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemiaP Richter-Pechańska, J B Kunz, J Hof, et al.
Nature Communications|June 26, 2020
Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemiaHend Abdelrasoul, Anila Vadakumchery, Markus Werner, et al.
Journal of Hematology & Oncology|January 17, 2025
Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed/refractory acute lymphoblastic leukemia in children and young adultsMaike Breidenbach, Peter Bader, Andishe Attarbaschi, et al.
Haematologica|February 15, 2024
Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukemia in children and young adultsTobias Feuchtinger, Peter Bader, Marion Subklewe, et al.
Pageof 55

Showing results (451-460 of 548) with videos related to

Sort By:
Pageof 55
Cell Reports. Medicine|April 29, 2023
Innate immune pathway modulator screen identifies STING pathway activation as a strategy to inhibit multiple families of arbo and respiratory virusesGustavo Garcia, Joseph Ignatius Irudayam, Arjit Vijey Jeyachandran, et al.
Cell Reports|October 14, 2025
Integrated genomic and transcriptomic profiling of glioblastoma reveals ecDNA-driven heterogeneity and microenvironmental reprogrammingWenshu Tang, Wing Lun Lee, Cario W S Lo, et al.
The Lancet. Haematology|December 4, 2018
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trialAndrea Biondi, Virginie Gandemer, Paola De Lorenzo, et al.
Haematologica|April 6, 2023
Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemiaJanina Heilmann, Simon Vieth, Anja Möricke, et al.
Nature Communications|June 7, 2016
Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemiaHenrik Lilljebjörn, Rasmus Henningsson, Axel Hyrenius-Wittsten, et al.
Blood Advances|July 15, 2024
A brain organoid/ALL coculture model reveals the AP-1 pathway as critically associated with CNS involvement of BCP-ALLPhilip Gebing, Stefanos Loizou, Sebastian Hänsch, et al.
Blood Cancer Journal|February 4, 2017
Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemiaP Richter-Pechańska, J B Kunz, J Hof, et al.
Nature Communications|June 26, 2020
Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemiaHend Abdelrasoul, Anila Vadakumchery, Markus Werner, et al.
Journal of Hematology & Oncology|January 17, 2025
Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed/refractory acute lymphoblastic leukemia in children and young adultsMaike Breidenbach, Peter Bader, Andishe Attarbaschi, et al.
Haematologica|February 15, 2024
Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukemia in children and young adultsTobias Feuchtinger, Peter Bader, Marion Subklewe, et al.
Pageof 55